Bristol Myers Squibb news and events in 2026
At Bristol Myers Squibb, we work every day to transform patients’ lives through science. That work inspires some of the most interesting, meaningful, and life-changing careers you’ll experience.
- Dated updates
- 114
- Last event
- Sep 29, 2026
- Open rolesSnapshot Sep 22, 2026
- 208
- Latest SEC filing
- Jul 30, 2026
Overview
Bristol Myers Squibb by topic
110-K filing
208open roles
2executive moves
71+signals
46 in the last 90 days
- Glassdoor15+
- LinkedIn15+
- Website changes15+
- X (Twitter)11
- and 4 more sources
Latest events
Latest Bristol Myers Squibb events
Showing 10 of 40 events. The Signal API returns all of them.
Get them with one API call- LayoffBristol Myers Squibb Announces Another 265 Layoffs, Extending Cuts Into 2027265 roles (reported)
- PartnershipNew Member Alert: RAAP WELCOMES BRISTOL MYERS SQUIBB! BMS Joins as Newest Member of RAAPWith Rare Access Action Project
- NewsNJ pharma giant cuts 265 more jobs - bringing 2026 layoffs to 718, so far265 roles (reported)
- PartnershipBristol Myers Squibb stock gains focus before October 29 results$15.2B · With Jiangsu Hengrui Pharma
- In developmentBMS’ neuro renaissance was built on back of Celgene mega-mergerBristol Myers Squibb is currently evaluating its drug Cobenfy in clinical trials for bipolar-1 mania, Alzheimer’s disease agitation, Alzheimer’s cognition and pediatric autism irritability.
- EarningsBristol Myers Squibb stock edges higher as merger talks and 2026 guidance shape outlookBristol Myers Squibb has set its fiscal 2026 guidance at a range of $6.75 to $7.00 in earnings per share.
- Investment
- Partnership endedBMS ends Cellares pact over cell therapy production problems, triggering layoffsBristol Myers Squibb has terminated its partnership with Cellares after determining that Cellares's cell therapy system did not meet the necessary requirements to manufacture the CAR T-cell immunotherapy Breyanzi.
- PartnershipBristol-Myers Squibb Stock: Zenbexus with FDA ApprovalWith Chai Discovery
- IntegrationChai Discovery Partners with Bristol Myers Squibb to Advance AI-Powered Antibody DiscoveryBristol Myers Squibb will integrate Chai Discovery's proprietary molecular folding and de novo design models across its drug discovery portfolio.
Showing 10 of 40 events. The Signal API returns all of them.
Get them with one API callSignal API · MCP
Track Bristol Myers Squibb with the Signal API
One POST /v1/companies/enrich call with bms.com returns every signal type for Bristol Myers Squibb, each with its source. Or ask Claude through MCP.
2 credits per signal returned; zero-result calls are free. Endpoint reference
curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"bms.com","limit":20}'Same industry
Companies related to Bristol Myers Squibb
Bristol Myers Squibb questions
What is the latest news on Bristol Myers Squibb?
What is going on with Bristol Myers Squibb?
Is Bristol Myers Squibb laying off employees?
What else does Autobound track for Bristol Myers Squibb?
Is Bristol Myers Squibb hiring right now?
Source. News, SEC filings (8-K, 10-K, 10-Q, Form D), hiring data and other signals (Reddit, podcasts, Glassdoor, reviews, social posts, patents, web traffic) from the Autobound Signal API.
Method. Stories are grouped when they report the same event within 14 days. Rows that do not name the company are removed. Each row links its source.
Data as of .